Considerations of schistosome physiology in the search for antibilharziasis drugs.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D002247:Carbon Isotopes; D003327:Coronary Disease / Q000503:physiopathology; D005260:Female; D005724:Ganglia / Q000502:physiology; D007422:Intestines / Q000166:cytology / Q000502:physiology; D010063:Ovum / Q000166:cytology; D011392:Proline / Q000378:metabolism; D012547:Schistosoma / Q000166:cytology / Q000502:physiology*; D012552:Schistosomiasis / Q000188:drug therapy; D014816:Vitelline Duct / Q000166:cytology / Q000502:physiology; D014817:Vitelline Membrane / Q000166:cytology
D000871:Anthelmintics; D002247:Carbon Isotopes; D011392:Proline